Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Aldeyra Therapeutics, Inc. , a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases, announced...
Amgen Receives NMPA Approval For Repatha In China To Reduce The Risk Of Cardiovascular Events
Amgen announced that the National Medical Products Administration (NMPA) has approved a new indication for Repatha as the first PCSK9 inhibitor in China for...
PeptiDream and Shionogi sign peptide drug conjugate discovery deal
PeptiDream has signed a deal with fellow Japanese pharmaceutical company Shionogi to discover and develop a series of blood-brain barrier (BBB) penetrating peptide drug...
TC BioPharm creates allogeneic cell banks for CAR T cancer therapy products
TC BioPharm (TCB), a developer of CAR-T immuno-oncology products, including Gamma Delta T (GDT) cell therapies, announced it has completed formulation of its first...
TrakCel and Quick partner to provide Digital Supply Chain IT solution for Cell and Gene Therapies
TrakCel, a UK-based developer of cell and gene therapy supply-chain tracking and orchestration systems software, and The Quick Life Science Group, a US-based provider...
Novartis and University of Oxford to establish AI based Drug Development Alliance
Novartis has partnered with the University of Oxford’s Big Data Institute (BDI) to boost drug development using artificial intelligence (AI) and advanced analytics.
The partners...
NeuroBo Pharmaceuticals to Initiate Phase III Clinical Trial of NB-01 in Adult Patients with Diabetic Neuropathic Pain
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases announced its plans to initiate a Phase III trial...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...